ArticleVirology journal2026
Pathological characteristics of coxsackievirus A14 in neonatal mice model.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
In recent years, with the increasing incidence of other non-EV-A71 enteroviruses, the research on other enteroviruses has become more and more important. Coxsackievirus A14 (CVA14), A member of the enterovirus group A, causes hand-foot-mouth disease (HFMD), aseptic meningitis and acute abdominal pain. In this study, we established the first ICR mouse model of CVA14 infection. The CVA14 HE27 strain was selected to infect neonatal mice through a preliminary experiment, and the infection model was established according to three different conditions of infection dose, route and age. It was found that 2-day-old ICR neonatal mice showed clinical symptoms such as hind limb paralysis and death after intramuscular injection of 105.75 TCID50 CVA14 HE27 strain. Through daily monitoring, we found that the viral load of skeletal muscle was the highest, and there were certain pathological changes in various tissues and organs, among which the changes of brain and skeletal muscle were the most obvious. The expression of pro-inflammatory cytokines IL-4, IL-10, IFN-γ and TNF-α were abnormally high. This neonatal mouse model of CVA14 infection will be useful for the development of prophylactic and therapeutic multivalent vaccines, as well as for the screening of antiviral drugs against enterovirus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.